ASX ends lower as CSL plunges on guidance downgrade, USD5b impairment
Make us a preferred source
Make us a preferred source on Google
The news: The Australian sharemarket ended lower as a double-digit selloff in biotech giant CSL pulled the healthcare segment 6.5% lower.
The benchmark ASX 200 index fell 0.49% to 8,701.8, with eight of the 11 sectoral indices in negative territory.
Biggest movers:
- CSL (-16.0%) — Downgraded its FY26 revenue and profit guidance and flagged a USD5 billion impairment across FY26 and FY27.
- Metcash (+6.6%) — Expects to deliver underlying profit of between $268 million and $270 million for FY26, which would be a decline from $275.5 million achieved in FY25.
Deal news:
- oOh!media (+7.1%) — Received a takeover offer from I Squared Capital that values the company at about $766 million, two weeks after receiving a lower priced offer from Pacific Equity Partners.
- Atlas Arteria (+0.2%) — Had a request to have IFM Investors’ $7 billion takeover offer declined by the Takeovers Panel.
Other news:
- Xero (-0.6%) — Issued an apology to customers for “disruptions you have experienced on our platform over the last five days” due to issues with the system and third party platform integrations.
- Dyno Nobel (+6.6%) — Reaffirmed EBIT guidance of between $460 million and $500 million, while downgrading its net interest expense guidance to between $100 million and $110 million.
- Humm Group (+8.0%) — Reached an agreement with activist shareholders Jeremy Raper and Collins Street Asset Management over the future of its board composition, which will see founder and largest shareholder Andrew Abercrombie resign from the board.
- Inghams (+7.4%) — Reiterated underlying EBITDA guidance of between $180 million and $200 million after recording a slight increase in core poultry volumes during the first nine months of the financial year.
